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76 Effect of season on the superstimulation response, embryo quality, and pregnancy establishment in dromedary
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The present study was conducted to study the effect of season on the superstimulation response, embryo quality and pregnancy establishment in the
dromedary camels. Two donors each were superstimulated in themonth of June 2019 (non-breeding season) and January 2019 (breeding season) by a
combination of 2500 IU of equine chorionic gonadotrophin (eCG, Folligon; Intervet), given as a single intramuscular injection on Day 1 of the
treatment protocol, and 400mg of pFSH (Folltropin; Bioniche) injected twice daily in declining doses of 2 80mg, 2 60mg, 2 40mg, and
2 20mg over 4 days, also beginning on Day 1. They were scanned by rectal ultrasonography and follicles counted before mating with a fertile bull
on Day 11 after the start of treatment. An injection of 20 mg of gonadotrophhin-releasing hormone (Receptal, Intervet) was given immediately after
mating to induce ovulation. The number of corpora lutea (CL) were counted, and the embryos collected by the non-surgical method on Day 7 after
ovulation. All embryoswere washed and graded before theywere transferred individually into the left uterine horn of recipient animals, synchronized
to be on Day 6 after ovulation. All recipients were screened by ultrasonography on Day 22, Day 60, and Day 90 for pregnancies. The data were
analysed using a two-sample t-test (Minitab statistical software,Minitab Ltd.). No difference was observed in themean number of follicles developed
(20.5 vs. 18.5) between the donors in breeding and non-breeding season, respectively. The percent mean s.e.m. of ovulations as observed by
counting the CL in nonbreeding season (80.7 3.4) were not different from those in breeding season (85.4 3.7). A total number of 16 embryos
collected during non-breeding season and 20 embryos in breeding season were transferred to recipients. The percent mean s.e.m. of pregnancies
established onDay 22 (56.6 3.4 vs. 67.5 7.5) and onDay 90 (47.2 2.8 vs. 60 0.0) were similar in both groups. These observations indicate that
embryo transfer technology can be applied to camels during the summer months, which is considered the non-breeding season, and pregnancies can
be established at par with breeding season. In conclusion, to the best of our knowledge, this is the first study in camels wherein we have demonstrated
that donor camels can be superstimulated, embryos can be collected, recipient animals can be synchronized, and pregnancies can be established in the
summer (non-breeding) months. The embryos collected from elite donors can be transferred to synchronized recipients to establish pregnancies or
preserved for future use. Some owners do not want calves to be born in summer months, so protocols need to be established for storing these embryos
for a few months before their transfer to recipients, to have the calves delivered in the desired winter months.
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CUnigranrio, Duque de Caxias, RJ, Brazil;
DUniversidade Paulista, São José dos Campos, SP, Brazil;
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The early regression of corpora lutea (ERCL) is a functional alteration that occurs more often in animals subjected to multiple ovulation followed by
embryo transfer (MOET) technique. Although it is mainly reported in goats, sheep are also susceptible to this disorder. The ERCL may compromise
the quality and viability of embryos, and even embryonic recovery rate. Thus, the non-diffusion of the animal genetic material on a commercial scale
increases costs, decreasing efficiency. This study aimed to assess the occurrence of ERCL in embryo donor ewes subjected to theMOET programs in
different seasons. The researchwas carried out in a commercial herd in São Luı́s do Paraitinga city (238220S and 458260W),Brazil, over 4 years (2017–
2020). Forty-four Dorper multiparous ewes aged between 3 and 9 years old andwith body condition score (BCS) between 2 and 4.5 (1 to 5 scale) were
used. Each ewe was used at least once for MOET and a maximum of 5 times, totalling 104 procedures. Regardless of the day of the oestrous cycle or
anovulatory period (Day 0), ewes received a conventional superovulatory protocol consisting of an intravaginal device treatment with 0.33mg of
progesterone (CIDR, Zoetis). On Day 7, the device was replaced with a new one and ewes administered i.m. 0.24mg of sodium cloprostenol
(Sincrocio, Ourofino). The superovulatory treatment [256mg of FSH (Folltropin, Vetoquinol)] started on Day 12 and consisted of decreasing
doses (20, 20, 15, 15, 10, 10, 5, and 5%) administered intramuscularly (IM) every 12 h for 4 days plus 200 IU of equine chorionic gonadotrophin (eCG,
Novormon, Zoetis) at device removal on Day 14 and 0.1mg of gonadotrophin-releasing hormone (Fertagyl, MSD) IM 1 day later (Day 15).
Laparoscopic AI was performed twice onDay 16 using cooled semen. Five days after AI, ovaries were assessed by laparoscopy to check the presence
and viability of corpora lutea (CL). Ewes that had avascular CL (pinkish to whitish colour) were classified as ERCL and embryo collection was not
performed. The occurrence of ERCL in each season and category of BCS was checked by either chi-squared or Fisher test. Logistic regression was
performed according to the incidence of ERCL in each category of age. Values of P, 0.05 were considered as significant. From 104 procedures,
ERCL was identified in 26 cases, totalling 25% of occurrence. The proportion of occurrence did not differ (P. 0.05) among seasons: breeding (10/
43: 23%), transition (10/36, 28%), or anoestrous (6/25, 24%). There was no difference in ERCL incidence in ewes presenting different BCS
categories: lower/thin (2 to 2.5: 3/12, 25%); average/good (3 to 3.5: 15/66, 22%) and higher/fat (4 to 4.5: 8/26, 31%). Indeed, there was no association
(P. 0.05) between ERCL and age. In conclusion, a relevant occurrence of ERCL was detected in superovulated embryo donor ewes but this
incidence was not associated with season, age, or BCS of Dorper ewes. These data highlight the importance of pharmacological measures to control
ERCL in MOET protocols for commercial sheep herds.
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The use of equine chorionic gonadotrophin (eCG) in oestrous induction protocols is associated with antibody production against eCG. Moreover,
there are important equine welfare issues involved in its production and the development of viable protocols without eCG in dairy goats is essential.
The aim of this study was to assess oestrus and ovulatory responses of short-term oestrous synchronization protocol with or without eCG in
nulliparous (NUL) and multiparous (MUL) dairy goats during the breeding season. On a random day of oestrous cycle (Day 0), Alpine (n¼ 10 NUL
and 10MUL), Nubian (n¼ 10NUL and 10MUL), and Saanen (n¼ 10NUL and 6MUL) goats received 30mg of D-cloprostenol intramuscularly (IM)
and an intravaginal sponge containing 60mg of medroxyprogesterone acetate, which was maintained for 6 days (Day 6). At 24 h before sponge
removal (Day 5), goats received IM 200 IU of Novormon 5000 (G-eCG) or saline solution (G-Control). NUL and MUL goats of each breed were
assigned equally into one of the two treatments. Transrectal ultrasonography was used to assess ovarian parameters, and teaser goats detected oestrus
every 12 h from sponge removal to ovulation or until 96 h after sponge removal. The results are described asmean s.e.m., and categorical results are
presented as percentages. The normal distribution of the residues of all variables was determined by the Shapiro-Wilk test and for homoscedastic by
Levene test. To evaluate interaction between treatments and parity order, the general linear model (GLM) was applied. Parametric variables were
subjected to Student’s t-test. Nonparametric variables were analysed by Mann–Whitney test, Chi-squared test, and Fisher’s exact test. Values of
P, 0.05 were considered significant. According to the breed and parity order, Nubian and Saanen goats showed no difference (P. 0.05) in
reproductive parameters. Alpine goats had a longer (P, 0.05) interval from sponge removal to onset of oestrus (SROE) in MUL (61 14.0 h) than
NUL (38.5 12.7 h), longer interval from onset of oestrus to ovulation (IEOV) in NUL (33.5 11.9 h) thanMUL (19.5 13.4 h), and the number of
ovulations was greater (P, 0.05) in MUL (2.2 0.9) than in NUL (1.3 0.5). In goats either receiving eCG or not, Alpine and Nubian goats had no
difference (P. 0.05) in SROE, IEOV, interval from sponge removal to ovulation (SROV), percentage of animals that ovulated, diameter of the
ovulatory follicle, and number of ovulations. Saanen goats had a higher (P, 0.05) percentage of animals that ovulated in G-eCG (87.5%) than
G-control (25.0%). Regardless of parity order and breed, SROVwas longer (P, 0.05) in G-control (73.2 9.8 h) than in G-eCG (65.1 10.2 h), and
the percentage of animals that ovulated was greater (P, 0.05) in G-eCG (96.4%) than in G-control (67.9%). In summary, in short-term protocols for
oestrous synchronization in cyclic dairy goats, the addition of eCG led to a shorter interval from sponge removal to ovulation and increased number of
animals that ovulated.
This research was supported by CNPq (310166/2012-8) and Embrapa (20.19.01.004.00.03.001).
115 Presynchronization and reutilization of progesterone devices during a 6-dayCO-Synch protocol for fixed-time
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Ovulatory response to the initial gonadotrophin-releasing hormone (GnRH) of the CO-Synch protocol is affected by circulating progesterone (P4)
and follicle size. In addition, heifers that ovulate to initial GnRH treatment have greater fertility after AI. Thus, the aim of this study was to assess the
effect of (1) presynchronization (Presynch) before a 6-day CO-Synch protocol and (2) P4 device reuse (new vs. second use) on ovulatory response,
oestrous expression, and pregnancy perAI (P/AI) in beef heifers. Yearling beef heifers (n¼ 233)were randomly assigned in a 2 2 factorial design to
the following treatments: (1) Treatment (Presynch): (1a) Presynchþ 6-day CO-Synch with new P4 device; (1b) Presynchþ 6-days CO-Synch with a
once-used P4 device; (2) Control (no Presynch): (2a) 6-day CO-Synch with new P4 device; (2b) 6-day CO-synch with once-used P4 device. Presynch
consisted of insertion of a new P4 intravaginal device (CIDR, 1.38 g of P4; Zoetis) on Day17 and removal of the CIDR on Day11 concurrently
with 500 mg of cloprostenol sodium. On Day 9, all heifers received either a new or once-used (used) CIDR and 100 mg of gonadorelin acetate
(GnRH, Parnell Inc.). Six days later (Day 3) CIDRs were removed, 1000mg of PGF was administered, and an oestrous detection patch applied
(Estrotect, Rockway Inc.). At 72 h after CIDR removal, 100 mg of GnRH and AI using 3 different sires was performed. Pregnancy was determined by
ultrasonography 31 days after AI. A subset of heifers (n¼ 151) were examined on Day9 and Day3 by ultrasonography to assess ovulation to Day
9 GnRH. Data were analysed using GLIMMIX (SAS 9.4; SAS Institute Inc.). Presynch heifers had larger follicle diameter on Day9 (12.7 0.3
vs. 10.4 0.3 mm; P, 0.0001), greater ovulatory response (84.6%; 66/78 vs. 52.05%; 38/73; P, 0.0001), greater oestrus expression (90.6%; 106/
117 vs. 78.4%; 91/116; P¼ 0.03), and expressed oestrus earlier (49.8 1.0 vs. 53.1 1.1 h; P¼ 0.01) compared with controls. There was an
interaction for treatment and CIDR on oestrous expression, whereas a lesser (P¼ 0.003) percentage of control heifers with newCIDR showed oestrus
compared with all other groups (Table 1). Heifers treated with a used P4 device tended (P¼ 0.08) to have greater P/AI (52.1%; 61/117) than those
with a new CIDR (40.5%; 47/116). In conclusion, presynchronization before initiation of a 6-day CO-Synch increased follicle diameter, ovulatory
response, and oestrous expression, but did not affect fertility. The earlier onset of oestrus in Presynch heifers warrants further study on timing of AI.
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Table 1. Oestrous expression and pregnancy per AI (P/AI) in beef heifers with or without presynchronization and treated with a new or used CIDR
Treatment CIDR Oestrus (%; n/n) Time of oestrus (h) P/AI (%; n/n)
Control New 67.8a (40/59) 53.7 1.5a 33.9 (20/59)
Used 89.5b (51/57) 52.7 1.6a 50.9 (29/57)
Presynch New 94.7b (54/57) 50.9 1.4b 47.4 (27/57)
Used 86.7b (52/60) 48.7 1.3b 53.3 (32/60)
P-value Treatment 0.03 0.01 0.21
CIDR 0.62 0.18 0.08
Interaction 0.003 0.78 0.38
a,bValues with different superscripts differ (P , 0.05).
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Hormonal oestrus induction treatment is an important tool for the success of reproductive biotechniques in anoestrus goats. In the nonbreeding season,
oestrus induction can be performed by the use of several protocols, including those varying in their duration. This study aimed to compare short-term
(for either 5 or 6 days) progestogen-based oestrus synchronization protocols in dairy [Toggenburg (n¼ 12) and Saanen (n¼ 12)] goats during the
nonbreeding season. This study was performed inMinas Gerais State, Brazil (218350S and 438150W), with 12 nulliparous (12–14 months old) and 12
pluriparous (2–4 years old in final third of lactation) goats, all with body condition scores (BCS) of 3.0 to 3.5. They were equally assigned to both
treatments according to their order of parturition, BCS, and breed. On a random day (Day 0), 24 goats received an intravaginal device of 60mg of
medroxyprogesterone acetate (Progespon, Zoetis) which remained for 5 (G5; n¼ 12) or 6 (G6; n¼ 12) days. On Day 5, goats from both groups
received 30mg of cloprostenol intramuscularly (IM) (Prolise, ARSAS.R.L.) and 200 IU of equine chorionic gonadotrophin (eCG) IM (Novormon,
Schering Plough Animal Health). Both groups received cloprostenol and eCG on the same day (regardless of device removal) to ensure they were
administered at the same follicular wave. Both device insertion and removal were performed in the morning. Ultrasound evaluations were performed
every 12 h from device removal to ovulation detection. Ovulations were considered as the average interval between the last observation of follicles
and the first exam in which it was no longer seen. The normal distribution of variables was determined by Shapiro-Wilk test and homocedasticity by
Levene’s test. All variables were not normally distributed and thus analysed by Mann–Whitney U test, with P, 0.05 considered significantly
different. Values are presented in median interquartile range. There was no difference between G5 and G6, respectively, in the interval to oestrus
(48.0 0.0 vs. 48.0 12.0 h), interval from oestrus onset to ovulation (18.0 9.0 vs. 18.0 12.0 h), interval from device removal to ovulation
(66.0 18.0 vs. 66.0 24.0 h), number of ovulated follicles (2.0 2.0 vs. 2.5 2.0), or mean diameter of ovulated follicles (6.6 1.6 vs.
6.6 1.4mm). All ovulations were detected in the morning. In conclusion, our data demonstrate that short-term hormonal treatment for 5 or 6 days is
similarly efficient to induce synchronous oestrus in Saanen and Toggenburg goats.
This research was supported by EMBRAPA (Project 20.19.01.004.00.03.001) and CNPq (314952/2018-7).
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Three experiments were designed to evaluate the effect of the length of insertion of a intravaginal progesterone (P4) device on follicular and corpus
luteum (CL) diameter, time of ovulation, and pregnancy rates following fixed-time AI (P/FTAI) in Bos indicus cows treated with an oestradiol/P4-
based treatment with a lengthened proestrus, named J-Synch. Multiparous suckled Bos indicus beef cows that were 35 to 60 days postpartum were
used in Experiments 1 and 2, whereas non-lactating cowswere used in Experiment 3. All cows had a CL or a follicle of at least 8mm in diameter and a
body condition score between 2.5 and 4 (1 to 5 scale) at the time of treatment. On Day 0, all cows received 2mg of oestradiol benzoate (EB;
Sincrodiol, Ourofino, Brazil) and a previously used intravaginal device (1 g of P4; Sincrogest, Ourofino). The P4 device was removed onDay 6 in the
J-Synch 6-day group and on Day 7 in the J-Synch 7-day and Control groups. All cows received 500 mg of cloprostenol (Sincrocio, Ourofino) and
400 IU of equine chorionic gonadotrophin (SincroeCG, Ourofino) at the time of P4 device removal, and cows in the Control group also received
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